Clinical Trial

Evaluation of Bile Acid Concentrations and Their Signaling as Markers of Testicular Tumorigenesis and Germ Cell Tumor Chemosensitivity

Name: Evaluation of Bile Acid Concentrations and Their Signaling as Markers of Testicular Tumorigenesis and Germ Cell Tumor Chemosensitivity — clinical trial record (NCT07463508)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: TG-BIL

Recruiting

View on ClinicalTrials.gov →

Summary

This is a study exploring measurable markers in the blood of patients with testicular tumors. The investigators will focus on the importance of measuring and analyzing these markers for their prognostic value and predictive response to treatment.

Trial Details

NCT Number	NCT07463508
Lead Sponsor	University Hospital, Clermont-Ferrand
Conditions	Testicular Germ Cell Cancer
Enrollment	20 participants
Start Date	2026-01-01
Primary Completion	2029-01-01 (estimated)
Study Completion	2029-01-01 (estimated)
Updated on ClinicalTrials.gov	2026-03-11